Epidemiology of candidemia: 3-Year results from the emerging infections and the epidemiology of Iowa organisms study

Journal of Clinical Microbiology

Volumn 40, Issue 4, 2002, Pages 1298-1302

  Diekema, Daniel J ^a   Messer, S A ^a   Brueggemann, A B ^a   Coffman, S L ^a   Doern, G V ^a   Herwaldt, L A ^a   Pfaller, M A ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; POSACONAZOLE; RAVUCONAZOLE; VORICONAZOLE;

ADOLESCENT; ADULT; AGED; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CHILD; FEMALE; FUNGUS ISOLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; UNITED STATES;

ADOLESCENT; ADULT; AGED; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, FUNGAL; FEMALE; FUNGEMIA; HUMANS; INCIDENCE; INFANT; IOWA; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; SENTINEL SURVEILLANCE;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; FUNGI;

EID: 0036204095     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.40.4.1298-1302.2002     Document Type: Article

References (20)

1. Trends in antifungal use and epidemiology of noscocomial yeast infections in a university hospital
2. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: The NEMIS Prospective Multicenter Study
3. Antifungal resistance in non-albicans Candida species
4. In vitro activities of BMS-207147 against over 600 contemporary clinical bloodstream isolates of Candida species from the SENTRY Antimicrobial Surveillance Program in North America and Latin America
5. Nosocomial bloodstream infections in United States hospitals: A three-year analysis
6. Identification of Candida dubliniensis based upon temperature and utilization of xylose and α-methyl as determined with the API 20C AUX and Vitek YBC systems
7. The epidemiology, of candidemia in two United States cities: Results of a population-based active surveillance
8. Fungal infections in older adults
9. International surveillance of bloodstream infections due to Candida species: Frequency of occurrence and in vitro susceptibility to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY Antimicrobial Surveillance Program
10. Bloodstream infections due to Candida species: SENTRY Antimicrobial Surveillance Program in North America and Latin America, 1997-1998
11. National Epidemiology of Mycoses Survey: A multicenter study of strain variation and antifungal susceptibility among isolates of Candida species
12. Evaluation of Etest for determining in vitro susceptibility of yeast isolates to amphotericin B
13. NationaI epidemiology of mycoses survey (NEMIS) variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units
14. Development of interpretive breakpoints for antifungal susceptibility testing: Conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and Candida infections
15. Practice guidelines for the treatment of candidiasis
16. Risk factors for candidemia in Neonatal Intensive Care Unit patients
17. Current and emerging azole antifungal agents
18. Hospital acquired candidemia: Attributable mortality and excess length of stay